i know when the share will spike, page-9

Hi all this is the best that my son could do hopefully it helps and is understood by all

Attached is the flow chart however the arrows didn't copy across the text has been reformatted orrespond with the attached flow chart

1. Re-introduction into Australia (approvals in place)
• Release in South East Asia
• Regulatory program Europe
• Regulatory program USA

2. a) New refined formulations
• Non-regulated
• Cosmetic
• Post Surgical


2. b) Out-License Fractions
• Biological Activity
• Fraction Indication
• Major pharmaceutical companies are currently reviewing the scientific portfolio


SUMMARY OF
CORPORATE OBJECTIVES
• To utilize existing approvals in Australia and Asia to generate revenues
• To utilize existing approvals and registrations to enable the clinical programs necessary for early entry into the European and US markets
• To utilize existing approvals to expand into new Rx indications
• To develop a range of OTC and professional cosmetic and non-therapeutic products
• To out-licence the fractionation and isolation opportunities for unique patentable entities